Autoimmunity in dengue virus infection

Dengue Bulletin

Volumn 28, Issue , 2004, Pages 51-57

  Lin, Chiou Feng ^a   Lei, Huan Yao ^a   Lui, Ching Chuan ^a   Lui, Hsiao Sheng ^a   Yeh, Trai Ming ^a   Chen, Shun Hua ^a   Lin, Yee Shin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Autoantibody; Dengue haemorrhagic fever; Dengue virus serotype; Endothelial cells

Indexed keywords

AUTOANTIBODY; DENGUE NONSTRUCTURAL PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CELL CULTURE; CELL INTERACTION; DENGUE; DENGUE VIRUS; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION PREVENTION; PROTEIN INTERACTION; SEROTYPE; TAIWAN; THROMBOCYTE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS TYPING;

DENGUE VIRUS;

EID: 19044364579     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clinical Microbiology Reviews, 1998, 11: 480-496.
2. Halstead SB. Dengue. Current Opinion in Infectious Diseases, 2002, 15: 471-476.
3. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition. Geneva: WHO, 1997.
4. World Health Organization. Dengue fever in Indonesia-update 4. 11 May 2004.
5. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science, 1988, 239: 476-481.
6. Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Advance in Virus Research, 2003, 60: 421-467.
7. Pang T. Vaccines for the prevention of neglected diseases - dengue fever. Current Opinion in Biotechnology, 2003, 14: 332-336.
8. Pugachev KV, Guirakhoo F, Trent DW and Monath TP. Traditional and novel approaches to flavivirus vaccines. International Journal of Parasitology, 2003, 33: 567-582.
9. Edelman R, Wasserman SS, Bodison SA, Putnak RJ, Eckels KH, Tang D, Kanesa-Thasan N, Vaughn DW, Innis BL and Sun W. Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. American Journal of Tropical Medicine and Hygiene, 2003, 69: 48-60.
10. Rothman AL. Dengue: defining protective versus pathologic immunity. Journal of Clinical Investigation, 2004, 113: 946-951.
11. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH and Liu CC. Immunopathogenesis of dengue virus infection. Journal of Biomedical Science, 2001, 8: 377-388.
12. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, Yang TI, Sheu FC, Kuo CF and Lin YS. Generation of IgM anti-platelet autoantibody in dengue patients. Journal of Medical Virology, 2001, 63: 143-149.
13. Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH and Lin YS. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. Journal of Medical Virology, 2003, 69: 82-90.
14. Lin YS, Lin CF, Lei HY, Liu HS, Yeh TM, Chen SH and Liu CC. Antibody-mediated endothelial cell damage via nitric oxide. Current Pharmaceutical Design, 2004, 10: 213-221.
15. Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Chiu SC and Lin YS. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. Journal of Immunology, 2002, 169: 657-664.
16. Lei HY, Huang JH, Huang KJ and Chang C. Status of dengue control programme in Taiwan - 2001. Dengue Bulletin, 2002, 26: 14-23.
17. Rothman AL and Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology, 1999, 257: 1-6.
18. Avirutnan P, Malasit P, Seliger B, Bhakdi S and Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. Journal of Immunology, 1998, 161: 6338-6346.
19. Lin YW, Wang KJ, Lei HY, Lin YS, Yeh TM, Liu HS, Liu CC and Chen SH. Virus replication and cytokine production in dengue virus-infected human B lymphocytes. Journal of Virology, 2002, 76: 12242-12249.
20. Hung NT, Lei HY, Lan NT, Lin YS, Huang KJ, Lien LB, Lin CF, Yeh TM, Ha DQ, Huong VTQ, Chen LC, Huang JH, My LT, Liu CC and Halstead SB. Dengue hemorrhagic fever in infants: a study on clinical and cytokine profiles. Journal of Infectious Diseases, 2004, 189: 221-232.
21. Falconar AK. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Archives of Virology, 1997, 142: 897-916.
22. Zhang YM, Hayes EP, McCarty TC, Dubois DR, Summers PL, Eckels KH, Chanock RM and Lai CJ. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. Journal of Virology, 1988, 62: 3027-3031.
23. Henchal EA, Henchal LS and Schlesinger JJ. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. Journal of General Virology, 1988, 69: 2101-2107.